Hypothesis

Aged human hearts accumulate senescent c‑Kit+ cardiac progenitor cells (CPCs) whose mitochondrial NAD+ depletion stabilizes HIF‑1α, amplifying NLRP3 inflammasome activity and skewing the senescence‑associated secretory phenotype (SASP) toward IL‑1β dominance. This IL‑1β‑rich SASP is packaged into exosomes enriched for miR‑34a, which are transferred to neighboring cardiomyocytes and endothelial cells, suppressing their proliferative capacity and perpetuating a regenerative block.

Mechanistic Basis

• NAD+ decline and HIF‑1α: In aging hematopoietic stem cells, NAD+ loss impairs SIRT3 activity, leading to mitochondrial ROS accumulation [2]. A parallel drop in NAD+ within cardiac c‑Kit+ CPCs would reduce SIRT3 deacetylation of HIF‑1α, allowing its stabilization even under normoxia. HIF‑1α transcriptionally upregulates NLRP3 and pro‑IL‑1β, biasing the SASP toward IL‑1β secretion.
• IL‑1β‑centric SASP: While SASP is heterogeneous, IL‑1β exerts potent paracrine senescence induction and inhibits cardiomyocyte cell‑cycle re‑entry via p21^CIP1^ upregulation [1]. An IL‑1β‑skewed secretome would therefore be more deleterious than a mixed SASP.
• Exosomal miR‑34a shuttling: IL‑1β signaling activates NF‑κB, which transcriptionally induces miR‑34a. Senescent CPCs load miR‑34a into exosomes via hnRNPA2B1‑dependent sorting. Exosome uptake by cardiomyocytes represses SIRT1 and cyclin D1, impairing proliferation and promoting fibrosis.
• Feedback loop: miR‑34a–mediated SIRT1 loss further elevates ROS and NAD+ consumption, deepening the metabolic defect in neighboring cells and propagating senescence.

Predictions and Experimental Design

1. Metabolic profiling: Isolated c‑Kit+ CPCs from young (<30 y) and aged (>65 y) human myocardium will show significantly lower NAD+/NADH ratios and higher HIF‑1α protein in the aged group (measured by LC‑MS and western blot).
2. SASP cytokine skew: Multiplex ELISA of CPC conditioned media will reveal a higher IL‑1β/(IL‑6+IL‑8) ratio in aged versus young cells.
3. Exosome miR‑34a enrichment: Exosomes purified from aged CPC media will contain >3‑fold more miR‑34a than those from young CPCs (qPCR).
4. Functional transfer: Treating neonatal rat cardiomyocytes with aged CPC exosomes will reduce EdU incorporation and increase p21 expression; this effect will be blocked by exosome GW4869 inhibition or miR‑34a antagomir.
5. In vivo rescue: Aged mice administered NAD+ precursor (NR) or SIRT1 activator (SRT2104) will exhibit decreased c‑Kit+ CPC HIF‑1α, lower IL‑1β SASP, reduced exosomal miR‑34a, and improved ejection fraction after ischemic injury compared with vehicle controls.

Each prediction is falsifiable: a lack of NAD+ decline, absent IL‑1β bias, or failure of exosomal miR‑34a to impair cardiomyocyte proliferation would refute the hypothesis.

Potential Implications

If validated, targeting NAD+ metabolism or the IL‑1β/miR‑34a axis could selectively rejuvenate the senescent c‑Kit+ CPC niche without broad senolytic clearance, preserving beneficial progenitor functions while halting paracrine damage. This approach may synergize with existing strategies such as CD36 neutralization or p16^INK4A^‑directed senolytics, offering a precision route to restore cardiac regeneration in aging.